Orion

Orion Current Assets

The Current Assets of Orion (271560.KS) as of Oct 14, 2026 is 321.48 B KRW. In the previous year, Current Assets was 558.77 B KRW — a change of -42.47% (lower).

Current Assets

321.48 BKRW

YoY

-42.47%

Last updated:

Current Assets of Orion is 2025 321.48 B KRW. Current Assets of Orion was 2024 558.77 B KRW. It decreases by -42.47% lower compared to the previous year.

The Orion Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
336.89 B KRW
Jan 1, 2019
365.06 B KRW
Jan 1, 2020
355.80 B KRW
Jan 1, 2021
420.78 B KRW
Jan 1, 2022
466.11 B KRW
Jan 1, 2023
507.53 B KRW
Jan 1, 2024
558.77 B KRW
Jan 1, 2025
321.48 B KRW
The Orion Current Assets history
YEARCurrent AssetsYoY
321.48 BKRW-42.47%
558.77 BKRW+10.10%
507.53 BKRW+8.89%
466.11 BKRW+10.77%
420.78 BKRW+18.26%
355.80 BKRW-2.54%
365.06 BKRW+8.36%
336.89 BKRW+12.70%
298.91 BKRW—
Access this data via the Eulerpool API

Orion Stock analysis

What does Orion do? Orion Corp is a Finnish company that operates in the pharmaceutical industry. The company was founded in 1917 and is headquartered in Espoo, Finland. Orion Corp specializes in the development, manufacturing, and marketing of medications, as well as the diagnosis and treatment of diseases. As one of the leading pharmaceutical companies in Finland, Orion Corp is dedicated to researching and developing medications and medical devices to help doctors and their patients worldwide improve their quality of life. Orion Corp's business model focuses on selling prescription and over-the-counter medications, as well as manufacturing generic medications. Additionally, the company is involved in the diagnosis and treatment of diseases such as Parkinson's, cancer, and asthma. The company's main business is centered around three main divisions: pharmaceuticals, diagnostics, and animal health. Within these divisions, Orion Corp has various business areas. In the pharmaceutical division, the focus is on developing medications to combat Parkinson's, cancer, and asthma. The company has a strong product range of Parkinson's treatments that can alleviate symptoms and slow the progression of the disease. Furthermore, the company is involved in the development of cancer medications that can inhibit the growth of cancer cells. Orion Corp is also a key player in asthma treatment. The company produces medications that expand the airways and make breathing easier. In the diagnostics division, Orion Corp's main business is the development and manufacturing of diagnostic devices for diseases such as lung cancer and asthma, as well as products for monitoring blood sugar and cholesterol. Animal health is another important business area for Orion Corp. The company manufactures medications and accessories for animal health and offers a variety of products to veterinarians and breeders. These include, for example, animal vaccines or hormone preparations to increase fertility in animals. Orion's production facilities are located in six countries, including Finland, Germany, France, Russia, the USA, and India. Production within the company primarily takes place in Finland. In addition to manufacturing medications and medical devices, Orion Corp is also a leading producer and developer of raw materials and intermediates for pharmaceutical applications worldwide. In summary, Orion Corp offers a wide range of products and services in the health and animal health fields using the latest scientific knowledge and technologies. The company remains committed to continuously expanding its product and service portfolio and providing patients worldwide with high-quality and effective medications that positively impact their lives. Orion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orion stock

Current Assets of Orion is 321.48 B KRW in 2025.

Current Assets of Orion changed from 558.77 B KRW to 321.48 B KRW, representing a -42.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Orion since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Orion historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Orion

All Key Metrics — Orion